Indian Journal of Cancer
Home  ICS  Feedback Subscribe Top cited articles Login 
Users Online :2877
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


TSC1/2 mutations as markers of response to everolimus in metastatic renal cell carcinoma: A case study

Jacob Linu A, Shafi Gowhar

Year : 2019| Volume: 56| Issue : 3 | Page no: 274-275

   This article has been cited by
1 Role of receptor tyrosine kinases mediated signal transduction pathways in tumor growth and angiogenesis—New insight and futuristic vision
Xiao Lin Huang, Muhammad Imran Khan, Jing Wang, Rizwan Ali, Syed Wajahat Ali, Qurat-ul-Ain Zahra, Ahsan Kazmi, Arbelo Lolai, Yu Lin Huang, Alamdar Hussain, Muhammad Bilal, Fenfen Li, Bensheng Qiu
International Journal of Biological Macromolecules. 2021; 180: 739
[Pubmed]  [Google Scholar] [DOI]
2 A Unique Case of Bilateral Thalamic High-Grade Glioma in a Pediatric Patient with LI-Fraumeni Syndrome: Case Presentation and Review of the Literature
Raffaella Messina, Gerardo Cazzato, Teresa Perillo, Vita Stagno, Valeria Blè, Mariachiara Resta, Francesco De Leonardis, Nicola Santoro, Francesco Signorelli, Giuseppe Ingravallo
Neurology International. 2021; 13(2): 175
[Pubmed]  [Google Scholar] [DOI]
3 mTOR signaling pathway and mTOR inhibitors in cancer: progress and challenges
Zhilin Zou, Tao Tao, Hongmei Li, Xiao Zhu
Cell & Bioscience. 2020; 10(1)
[Pubmed]  [Google Scholar] [DOI]
4 Everolimus
Reactions Weekly. 2019; 1769(1): 195
[Pubmed]  [Google Scholar] [DOI]


  Site Map | What's new | Copyright and Disclaimer | Privacy Notice
  Online since 1st April '07
  © 2007 - Indian Journal of Cancer | Published by Wolters Kluwer - Medknow